EVALUATING NORMAL GLYCEMIC EFFECT OF STEM EXTRACTS OF ABRUS PRECATORIUS IN STZ-INDUCED DIABETIC WISTAR RATS
Abstract
Diabetes mellitus (DM) is a widespread metabolic disorder, particularly in developing regions where access to effective and affordable treatment remains a challenge. This study evaluated the antidiabetic efficacy, safety, and biochemical impacts of aqueous (AE) and methanolic (ME) extracts of Abrus precatorius stem in streptozotocin (STZ)-induced diabetic Wistar rats. Phytochemical screening revealed the presence of key bioactive compounds, including flavonoids, alkaloids, saponins, tannins, and glycosides. Acute toxicity tests confirmed a high safety margin for both extracts. Diabetic rats treated orally with AE and ME at doses of 100, 200, and 400 mg/kg over 14 days showed significant, dose-dependent reductions in fasting blood glucose levels. The highest doses (400 mg/kg) of both extracts nearly restored glucose levels to those of normal controls, comparable to the standard drug glibenclamide. Additionally, treatment improved lipid profiles by lowering total cholesterol, triglycerides, and low density lipoprotein (LDL) levels while increasing high density lipoprotein (HDL), with the ME-400 group showing slightly superior effects. Liver enzyme analysis revealed that diabetes-induced elevations in ALT and reductions in AST were modulated by the extracts, indicating hepatoprotective potential. The methanolic extract, likely due to better extraction of nonpolar bioactives, demonstrated slightly more pronounced therapeutic effects across biochemical parameters. These findings suggest that Abrus precatorius stem extracts, particularly at higher doses, exhibit potent antihyperglycemic, lipid-lowering, and hepatoprotective properties. Therefore, this result supports their potential use as safe, effective, natural and accessible therapeutic agents in the management of diabetes mellitus especially in low-resource healthcare settings.
References
Afolayan, A. J. and Sunmonu, T. O. (2010). In vivo studies on antidiabetic plants used in South African herbal medicines. Journal of Clinical Biochemistry and Nutrition, 47, 98-106.
American Diabetes Association (ADA) (2018). 10 Microvascular complications and foot care: standards of medical care in diabetes Diabetes Care, 41 (Supplement 1), S105S118.
Anand, U., Tudu, C. K., Nandy, S., Sunita, K., Tripathi, V., Loake, G. J. and Prokw, J. (2022). Ethnodermatological use of medicinal plants in India: From ayurvedic formulations to clinical perspectivesA review. Journal of ethnopharmacology, 284, 114744.
Atmakuri, L. R., and Dathi, S. (2010). Current trends in herbal medicines. Journal of Pharmaceutical Research, 3, 109-113.
Bhatia M., NA S., Gupta S., Abrus Precatorius (L.): An Evaluation of Traditional Herb, Indo American Journal of Pharmaceutical Research, 2013 ISSN NO: 2231-6876.
Bommer, C., Heesemann, E. C. N. and Sagalova, V. (2017). The global economic burden of diabetes in adults aged 20-79 years: a cost-of-illiness study. Lancet Diabetes Endocrinology, 5 (6), 423-430.
Chaudhari S. K., Sharma, R., Pawar, S. P. and Kashikar A. V. (2012). Pharmacological activities of Abrus precatorius Linn. A Review. International Journal of Ayurvedic and Herbal Medicine, 2(2), 336-348.
Ding, X., Giannenas, I., Skoufos, I., Wang, J. and Zhu, W. (2022). The effects of plant extracts on lipid metabolism of chickensA review. Animal bioscience, 36(5), 679.
Duan, H., Song, P., Li, R., Su, H. and He, L. (2023). Attenuating lipid metabolism in atherosclerosis: The potential role of Anti-oxidative effects on low-density lipoprotein of herbal medicines. Frontiers in pharmacology, 14, 1161657.
Elflein, J. (2019). Diabetics worldwide 2017 and 2045. Statista Nigeria, Health & Pharmaceuticals.
Gracelin, D. H., Britto A.J. and Kumar, B. J. R. (2012). Qualitative and quantitative analysis of Phytochemicals in five Pteris species. International Journal of Pharmacy and Pharmaceutical Sciences, 5, 105-107.
Gupta, A., Kumar, R., Ganguly, R., Singh, A. K., Rana, H. K. and Pandey, A. K. (2021). Antioxidant, anti-inflammatory and hepatoprotective activities of Terminalia bellirica and its bioactive component ellagic acid against diclofenac induced oxidative stress and hepatotoxicity. Toxicology reports, 8, 44-52.
Igbashio, M. D., Eluehike, N and Oriakhi, K. (2025),Liver function and biomarkers of oxidative stress levels in streptozotocin-induced diabetic rats treated with leave extract of carica papaya. FUDMA journal of science (FJS) 5, 222-231
Jyotsna, F. N. U., Ahmed, A., Kumar, K., Kaur, P., Chaudhary, M. H., Kumar, S. and Kakadiya, K. A. (2023). Exploring the complex connection between diabetes and cardiovascular disease: analyzing approaches to mitigate cardiovascular risk in patients with diabetes. Cureus, 15(8).
Malviya, N., Jain, S. and Malviya, S. (2010). Antidiabetic potential of medicinal plants. Acta Poliniae Pharmaceutica-Drug Research, 67 (2), 113-118.
Murtala, A. A., Oladapo, O. E., Aderionla, A. A., Olooto, W. E., Soyinka, O. O., Folarin, R. O. and Abolarinwa, J. A. (2023). Sub-chronic (ninety days) toxicity study of hydroethanolic leaf extract of Datura stramonium L. in rodents. Clinical Complementary Medicine and Pharmacology, 3(3), 100090.
Nwozo, O. S., Effiong, E. M., Aja, P. M. and Awuchi, C. G. (2023). Antioxidant, phytochemical, and therapeutic properties of medicinal plants: A review. International Journal of Food Properties, 26(1), 359-388.
Ocho-Anin Atchibri, A. L., Brou, K. D., Kouakou, T. H., Kouadio, Y. J. and Gnakri, D. (2010). Screening for antidiabetic activity and phytochemical constituents of common bean (Phaseolus vulgaris L.) seeds. Journal of Medicinal Plants Research, 4 (17), 1757-1761.
Ojezele, M. O. and Abatan, O. M. (2011). Hypoglycaemic and coronary risk index lowering effects of Bauhinia thoningii in alloxan induced diabetic rats. African Health Science, 11 (1), 85-89.
Prabha P.M., Perumal P.C., Kumar M. P., S. and Sampath K. R. (2015). Pharmacological activities of Abrus precatorius (L.) seeds, International Journal of Pharmaceutical and Medicinal Research, 3(2), 195-200.
Rastigo AK, Chander R, and Srivastava KA (1977). Screening of natural products for hypolipidaernic and
hypoglycaemic activities. In: Proceedings in International workshop on Medicinal plants their bioactivity, screening and evaluation.
Scoditti, E., Sabatini, S., Carli, F. and Gastaldelli, A. (2024). Hepatic glucose metabolism in the steatotic liver. Nature Reviews Gastroenterology & Hepatology, 1-16.
Vijayan, S. and Thirumal, M. (2024). Systematic review on Abrus precatorius Linn. since 1871: ethnobotanical uses, phytochemistry and pharmacological properties. Phytochemistry Reviews, 1-30.
Copyright (c) 2025 FUDMA JOURNAL OF SCIENCES
This work is licensed under a Creative Commons Attribution 4.0 International License.
FUDMA Journal of Sciences
